Commercialization and development of high-quality enzymes and reagents for molecular biology applications. EnzyQuest’s team consists of researchers of Minotech Biotechnology, the in-house biotechnology production facility of IMBB-FORTH.

EnzyQuest’s technology and expertise on large scale protein expression, enzyme purification and engineering allow them to evaluate and develop new enzyme products and the highest quality reagents at a most valuable offer / pricing and in a time effective manner. EnzyQuest’s research and discovery currently focuses on extremophiles, i.e., enzymes adapted at extreme conditions (temperature, salinity, pH, organic solvents), that offer considerable advantages to the available commercial ones. The company has also developed a multiplex Covid-19 test kit that comprises proprietary enzymes and protocol.